Aishwarya Gurumurthy

Aishwarya Gurumurthy

Auto-generated profile, based on publicly available information

Aishwarya Gurumurthy

Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Blood Cancer Discovery
Verified
Journal Article
Closed access
PDF file
RKRohan Kodgule
Rohan Kodgule
JGJoshua W. Goldman
Joshua W. Goldman
AMAlexander C. Monovich
Alexander C. Monovich
TSTravis Saari
Travis Saari
AAAthalee R. Aguilar
Athalee R. Aguilar
RRRussell J. H. Ryan
Russell J. H. Ryan
Distal enhancers play critical roles in sustaining oncogenic gene-expression programs. We identify aberrant enhancer-like activation of GGAA tandem repeats as a characteristic feature of B-cell acute lymphoblastic leukemia (B-ALL) with genetic defects of the ETV6 transcriptional repressor, including ETV6–RUNX1+ and ETV6-null B-ALL. We show that GGAA repeat enhancers are direct activators of previously identified ETV6–RUNX1+/− like B-ALL “signature” genes, including the likely leukemogenic driver EPOR. When restored to ETV6-deficient B-ALL cells, ETV6 directly binds to GGAA repeat enhancers, represses their acetylation, downregulates adjacent genes, and inhibits B-ALL growth. In ETV6-deficient B-ALL cells, we find that the ETS transcription factor ERG directly binds to GGAA microsatellite enhancers and is required for sustained activation of repeat enhancer-activated genes. Together, our findings reveal an epigenetic gatekeeper function of the ETV6 tumor suppressor gene and establish microsatellite enhancers as a key mechanism underlying the unique gene-expression program of ETV6–RUNX1+/− like B-ALL. Significance: We find a unifying mechanism underlying a leukemia subtype-defining gene-expression signature that relies on repetitive elements with poor conservation between humans and rodents. The ability of ETV6 to antagonize promiscuous, nonphysiologic ERG activity may shed light on other roles of these key regulators in hematolymphoid development and human disease. See related commentary by Mercher, p. 2. This article is highlighted in the In This Issue feature, p. 1

11 March 2025 in Blood Cancer Discovery
Verified
Journal Article
Closed access
AIAshwin R. Iyer
Ashwin R. Iyer
AGAishwarya Gurumurthy
Aishwarya Gurumurthy
SCShih-Chun A. Chu
Shih-Chun A. Chu
RKRohan Kodgule
Rohan Kodgule
AAAthalee R. Aguilar
Athalee R. Aguilar
RRRussell J.H. Ryan
Russell J.H. Ryan
High expression of MYC and its target genes identify germinal center B-cell diffuse large B-cell lymphomas (GCB-DLBCL) associated with poor outcomes. We used CRISPR-interference profiling of human lymphoma cell lines to define essential enhancers in the MYC locus and non-immunoglobulin rearrangement partner loci, including a recurrent rearrangement between MYC and the BCL6 locus control region. GCB-DLBCL cell lines without MYC rearrangement were dependent on an evolutionarily conserved enhancer we name “GC B cell MYC enhancer 1,” which was found to be activated by the transcription factor complex of OCT2, OCA-B, and MEF2B, showed an active chromatin state in normal human and mouse GC B cells, and demonstrated selective acetylation and MYC promoter topological interactions in MYC-intact GCB-DLBCL biopsies. Whole-genome sequencing identified tandem copy gains of GC MYC enhancer 1 as a rare but recurrent event in DLBCL. Our findings shed new light on mechanisms that dysregulate MYC, a key driver of B-cell malignancy. Significance: Aberrant MYC activity defines the most aggressive GCB-DLBCLs. We characterized a mechanism of MYC transcriptional activation via a native enhancer that is active in MYC-intact GCB-DLBCL, establishing fitness-sustaining cis- and trans-regulatory circuitry in GCB-DLBCL models that lack MYC enhancer-hijacking rearrangement. See related commentary by Mulet-Lazaro and Delwel, p. 149

5 May 2025
Verified
Other
Open access
PDF file
AIAshwin R. Iyer
Ashwin R. Iyer
AGAishwarya Gurumurthy
Aishwarya Gurumurthy
SCShih-Chun A. Chu
Shih-Chun A. Chu
RKRohan Kodgule
Rohan Kodgule
AAAthalee R. Aguilar
Athalee R. Aguilar
RRRussell J.H. Ryan
Russell J.H. Ryan
Supplementary figures S1-S7, showing additional information relevant to the corresponding main figure.


4 April 2023
Verified
Other
Open access
RKRohan Kodgule
Rohan Kodgule
JGJoshua W. Goldman
Joshua W. Goldman
AMAlexander C. Monovich
Alexander C. Monovich
TSTravis Saari
Travis Saari
AAAthalee R. Aguilar
Athalee R. Aguilar
RRRussell J.H. Ryan
Russell J.H. Ryan
Supplementary Table 3 summarizes TF ChIP-Seq results and motif enrichment statistics